Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor

Transplant Infectious Disease

Volumn 16, Issue 1, 2014, Pages 44-54

  Hassig A ^a   Roos, M ^b   Etter, A ^a   Bossart, W ^c   Muller N ^a   Schiesser, M ^a   Wuthrich R P ^a   Fehr, T ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Acute rejection; BK nephropathy; BK virus; HLA matching; Immunosuppression; Kidney transplantation; Polyomavirus associated nephropathy

Indexed keywords

ACUTE REJECTION; BK NEPHROPATHY; BK VIRUS; HLA MATCHING; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; POLYOMAVIRUS-ASSOCIATED NEPHROPATHY;

ADULT; AGED; ALLOGRAFTS; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; BK VIRUS; COHORT STUDIES; CYCLOSPORINE; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOPHENOLIC ACID; POLYOMAVIRUS INFECTIONS; PROTEINURIA; PYRROLES; QUINAZOLINES; RECOMBINANT FUSION PROTEINS; TACROLIMUS; TUMOR VIRUS INFECTIONS; VIREMIA;

EID: 84893847489     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12153     Document Type: Article

References (25)

1. Morris PJ. Transplantation-a medical miracle of the 20th century. N Engl J Med 2004; 351 (26): 2678-2680.
2. Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP. BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005; 68 (4): 1834-1839.
3. Bohl DL, Brennan DC. BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2007; 2 (Suppl 1): S36-S46.
4. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13 (8): 2145-2151.
5. Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant 2010; 10 (12): 2615-2623.
6. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347 (7): 488-496.
7. Hirsch HH. Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Am J Transplant 2002; 2 (1): 25-30.
8. Renoult E, Coutlee F, Paquet M, et al. Evaluation of a preemptive strategy for BK polyomavirus-associated nephropathy based on prospective monitoring of BK viremia: a kidney transplantation center experience. Transplant Proc 2010; 42 (10): 4083-4087.
9. Dheir H, Sahin S, Uyar M, et al. Intensive polyoma virus nephropathy treatment as a preferable approach for graft surveillance. Transplant Proc 2011; 43 (3): 867-870.
10. Chang CY, Gangji A, Chorneyko K, Kapoor A. Urological manifestations of BK polyomavirus in renal transplant recipients. Can J Urol 2005; 12 (5): 2829-2836.
11. Budde K, Sommerer C, Becker T, et al. Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients. Am J Transplant 2010; 10 (3): 571-581.
12. Bernhoff E, Tylden GD, Kjerpeseth LJ, Gutteberg TJ, Hirsch HH, Rinaldo CH. Leflunomide inhibition of BK virus replication in renal tubular epithelial cells. J Virol 2010; 84 (4): 2150-2156.
13. Hirsch HH, Mohaupt M, Klimkait T. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 2001; 184 (11): 1494-1495.
14. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3 (10): 611-623.
15. Weiss AS, Gralla J, Chan L, Klem P, Wiseman AC. Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies. Clin J Am Soc Nephrol 2008; 3 (6): 1812-1819.
16. Ramos E, Drachenberg CB, Wali R, Hirsch HH. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation 2009; 87 (5): 621-630.
17. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5 (3): 582-594.
18. Prince O, Savic S, Dickenmann M, Steiger J, Bubendorf L, Mihatsch MJ. Risk factors for polyoma virus nephropathy. Nephrol Dial Transplant 2009; 24 (3): 1024-1033.
19. Hirsch HH, Vincenti F, Friman S, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant 2013; 13 (1): 136-145.
20. Perez-Torres D, Bertran-Pasarell J, Santiago-Delpin E, et al. Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population. Transpl Infect Dis 2010; 12 (1): 16-22.
21. Mengel M, Marwedel M, Radermacher J, et al. Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003; 18 (6): 1190-1196.
22. Awadalla Y, Randhawa P, Ruppert K, Zeevi A, Duquesnoy RJ. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant 2004; 4 (10): 1691-1696.
23. Drachenberg CB, Papadimitriou JC, Mann D, Hirsch HH, Wali R, Ramos E. Negative impact of human leukocyte antigen matching in the outcome of polyomavirus nephropathy. Transplantation 2005; 80 (2): 276-278.
24. Comoli P, Binggeli S, Ginevri F, Hirsch HH. Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl Infect Dis 2006; 8 (2): 86-94.
25. Han Lee ED, Kemball CC, Wang J, et al. A mouse model for polyomavirus-associated nephropathy of kidney transplants. Am J Transplant 2006; 1: 913-922.